subgroup of
vaccine)
→
ReceivesAction
→
developed
| Typicality: | 0.685 |
| Saliency: | 1.000 |
| currently | 2 | temporal |
| cancer vaccine → be → developed | 4 |
| cancer vaccine → be → studied | 3 |
| negative | neutral | positive |
| 0.152 | 0.483 | 0.365 |
| Raw frequency | 7 |
| Normalized frequency | 1.000 |
| Modifier score | 0.525 |
| Perplexity | 270.366 |